针作为阿尔茨海默氏病的补充疗法
Haixia Li1, Qiongyao Xiang2, Rujing Ren1
1Department of Neurology and Institute of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Journal of Alzheimer's disease : JAD
|October 18, 2024
概括
针作为阿尔茨海默氏病 (AD) 的非药物治疗方法显示出前景. 研究强调了其临床应用,治疗机制,以及在AD治疗中补充传统疗法的潜力.
科学领域:
- 神经科学是一个神经科学.
- 综合医学是一个整体医学.
- 老年学是一门学科.
背景情况:
- 阿尔茨海默病 (AD) 是一个日益增长的全球健康挑战,其特点是认知能力下降和行为改变.
- 目前针对阿尔茨海默症的药理疗法具有有限的疗效.
- 针正在成为一种可行的非药物干预方法来治疗AD.
研究的目的:
- 审查针在阿尔茨海默病中的临床应用.
- 探索在AD中针的作用背后的神经生物学机制.
- 讨论在AD治疗中针的当前局限性和未来研究方向.
主要方法:
- 关于治疗阿尔茨海默病的针的临床前和临床研究的综合文献综述.
- 对针作用机制的神经生物学研究的分析.
- 关于针参数和组合疗法的临床数据的综合.
主要成果:
- 针证明了治疗疗效和独特的优势在管理AD症状.
- 神经生物学证据支持针在阿尔茨海默病治疗中的作用.
- 有潜力将针与常规药物和其他疗法结合起来.
结论:
- 针是阿尔茨海默病的一个有前途的补充疗法.
- 需要进一步的研究来优化针方案,并充分了解其机制.
- 针即将成为阿尔茨海默病的重要治疗选择,随着研究的进步.
更多相关视频
03:26Author Spotlight: Improving Anesthesia Protocols for Enhanced Mouse Acupuncture Research
Published on: December 8, 2023
1.1K
08:27Establishment of a Valuable Mimic of Alzheimer's Disease in Rat Animal Model by Intracerebroventricular Injection of Composited Amyloid Beta Protein
Published on: July 29, 2018
11.8K
相关概念视频
01:22Alzheimer's Disease: Treatment
165
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
165
01:26Alzheimer's Disease: Overview
449
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
449